Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma Patients (N = 119) with ≥one ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results